Recently, the probiotic research and development company “BIODEP” received a new round of investment from CMB International Capital Holdings and GF Xinde Investment. This is BIODEP’s second financing in the past six months, bringing the total amount raised to several hundred million yuan (several tens of millions USD). BIODEP is a high-tech enterprise specializing in the full industry chain research, production, and sales of microbial probiotics. The company holds patented strains, core production equipment, and commercial production capabilities, providing solutions for the health, pharmaceutical, dairy, food, and modern agriculture industries. Its products include probiotic powders, ODM probiotic products, dairy formulations, and livestock fermentation agents. Additionally, the company exports its products to 20 countries and regions, including the Americas, Europe, and Australia, and holds nearly a hundred patents. (Source: FoodTalks)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE